© The Financial Times Ltd 2015 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Jul 28, 2015, the consensus forecast amongst 32 polled investment analysts covering GlaxoSmithKline plc advises investors to hold their position in the company. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Feb 21, 2013. The previous consensus forecast advised that GlaxoSmithKline plc would outperform the market.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 26 analysts offering 12 month price targets for GlaxoSmithKline plc have a median target of 1,535, with a high estimate of 1,800 and a low estimate of 1,300. The median estimate represents a 15.54% increase from the last price of 1,328.5. View Full Financials
In 2014, GlaxoSmithKline PLC reported a dividend of 0.80 GBP, which represents a 2.56% increase over last year. The 24 analysts covering the company expect dividends of 0.92 GBP for the upcoming fiscal year, an increase of 14.50%. View Full Financials
|Div growth (TTM)||+2.56 %|
On May 06, 2015, GlaxoSmithKline plc reported 1st quarter 2015 earnings of 0.173 per share. This result was in line with the consensus of the 6 analysts following the company and under-performed last year's 1st quarter results by 17.62 %.
The next earnings announcement is expected on Jul 29, 2015. View Full Interim Financials
|Average growth rate||-1.21 %|
GlaxoSmithKline plc reported annual 2014 earnings of 0.954 per share on Feb 04, 2015.
The next earnings announcement from GlaxoSmithKline plc is expected the week of Feb 08, 2016. View Full Annual Financials
|Average growth rate||-7.49 %|
GlaxoSmithKline plc had 1st quarter 2015 revenues of 5.62bn. This bettered the 5.62bn consensus of the 6 analysts covering the company. This was 0.16% above the prior year's 1st quarter results. View Full Interim Financials
|Average growth rate||+0.26 %|
GlaxoSmithKline plc had revenues for the full year 2014 of 23.01bn. This was 13.20 % below the prior year's results. View Full Annual Financials
|Average growth rate||-4.99 %|